Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin acetate as add-on therapy in patients with schizophrenia
IRCT201208071556N45Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin in schizophrenia, sponsored by Tehran University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
desmopressin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT201208071556N45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208071556N45.